CAS: 129580-63-8 - Satraplatin
Formula:C10H22Cl2N2O4Pt
InChI:InChI=1S/C6H13N.2C2H4O2.2ClH.H3N.Pt/c7-6-4-2-1-3-5-6;2*1-2(3)4;;;;/h6H,1-5,7H2;2*1H3,(H,3,4);2*1H;1H3;/q;;;;;;+4/p-4
InChI key:InChIKey=CKNPWBAXEKSCRG-UHFFFAOYSA-J
SMILES:O=C([O-][Pt+4]([Cl-])([Cl-])([O-]C(=O)C)([NH3])[NH2]C1CCCCC1)C
- Synonyms:
- Bis(acetato-O)amminedichloro(cyclohexanamine)-pt
- Bms 182751
- Bmy 45594
- Cyclohexanamine, platinum complex
- Jm 216
- POplat
- Platinum (lV) cis-dichloro-trans-bis(acetato-O)ammine(cyclohexanamine)
- Platinum(4+) Chloride Acetate Cyclohexanamine Ammoniate (1:2:2:1:1)
- Platinum, bis(acetato-O)amminedichloro(cyclohexanamine)-, (OC-6-43)-
- Platinum, bis(acetato-κO)amminedichloro(cyclohexanamine)-, (OC-6-43)-
- See more synonyms
Platinum, bis(acetato-κO)amminedichloro(cyclohexanamine)-, (OC-6-43)- (9CI)
CAS:129580-63-8
Formula:
C10H24Cl2N2O4Pt
Molecular weight:
502.2926
Ref: AN-AG000Z8P
5mg | To inquire | |
25mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 2 May 2024
Satraplatin
CAS:129580-63-8
Formula:
C10H22Cl2N2O4Pt
Purity:
≥ 98.0%
Color and Shape:
White to light yellow powder
Molecular weight:
500.28
Ref: 7W-GP7844
Undefined size | To inquire |
Estimated delivery in United States, on Friday 3 May 2024
Satraplatin
CAS:129580-63-8
Satraplatin (BMS182751) is an orally available antineoplastic platinum(IV) complex.Satraplatin has a favorable toxicity profile and …
Formula:
C10H22Cl2N2O4Pt
Purity:
98%
Color and Shape:
Solid
Molecular weight:
500.28
Ref: TM-T7221
1mg | 134.00 € | |
5mg | 303.00 € | |
10mg | 440.00 € | |
25mg | 722.00 € | |
50mg | 1,016.00 € | |
100mg | 1,361.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
Satraplatin
CAS:129580-63-8
Platinum-based chemotherapeutic agent
Formula:
C10H22Cl2N2O4Pt
Purity:
Min. 95%
Color and Shape:
Slightly Yellow Powder
Molecular weight:
500.28 g/mol
Ref: 3D-FS65158
10mg | 109.00 € | |
50mg | 343.00 € |
Estimated delivery in United States, on Monday 13 May 2024